Strategic Partnerships
PMK Group & UniPrisma
Innovation in biotechnology and medtech only matters if it reaches patients.
That’s the principle behind our partnership with UniPrisma.
Together, we are building a bridge between academic research and clinical reality, turning scientific progress into viable medical and diagnostic solutions.
UniPrisma brings strong academic roots, connecting universities, researchers, and inventors with early-stage development and commercialization. PMK Group contributes operational and investment expertise from clinical trial management to regulatory navigation and venture acceleration.
Our shared focus is clear:
Support promising biotech and medtech founders and teams from Europe and Asia
Help early innovations reach clinical validation faster and with less risk
Combine research quality with real-world implementation
This collaboration reflects what we both believe: that science, when supported by execution and accountability, becomes impact.
“In biotech and medtech, good science is only the beginning. Without structure, capital, and the right partners, innovation stops at the lab bench. Together with UniPrisma, we make sure it doesn’t.”
— Dr. Peter M. Kovacs, Founder & CEO, PMK Group